With the addition of the Wellstar Paulding residency, Wellstar will soon support more than 860 physicians in training statewide
Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
13,18,24,31 These commonly include midface descent and loss of volume
Volume Depletion Inform patients that symptomatic hypotension may occur with JARDIANCE and advise them to contact their healthcare provider if they experience such symptoms [see Warnings and Precautions (5.2)]
Your injection day becomes a key part of your routine
GLP-1 therapy is administered via subcutaneous injection once a week